Levonorgestrel Vaginal Delivery System 75

DRUG2 trials

Sponsors

Chemo Research S.L.

Conditions

Prevention of pregnancy

Phase 3

A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 9 cycles in comparison with Desogestrel tablets 0.075 mg.

CompletedCTIS2022-502024-51-00

Chemo Research S.L.Prevention of pregnancy

Start: 2023-07-12End: 2025-03-26Target: 1356Updated: 2025-04-15

A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.

CompletedCTIS2022-502023-21-00

Chemo Research S.L.Prevention of pregnancy

Start: 2023-07-12End: 2025-08-01Target: 1037Updated: 2025-06-03